Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    NextWave Pharms

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3NEXTWAVE PHARMS

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    NEXTWAVE PHARMS

    METHYLPHENIDATE HYDROCHLORIDE

    arrow
    The Generic Rx Session
    Not Confirmed

    NEXTWAVE PHARMS

    U.S.A
    arrow
    The Generic Rx Session
    Not Confirmed

    Patent Expiration Date : 2033-08-14

    METHYLPHENIDATE HYDROCHLORIDE

    US Patent Number : 9295642

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 207960

    Patent Use Code : U-1827

    Delist Requested :

    Patent Use Description : A METHOD OF PROVIDING ...

    Patent Expiration Date : 2033-08-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    NEXTWAVE PHARMS

    METHYLPHENIDATE HYDROCHLORIDE

    arrow
    The Generic Rx Session
    Not Confirmed

    NEXTWAVE PHARMS

    U.S.A
    arrow
    The Generic Rx Session
    Not Confirmed

    Patent Expiration Date : 2033-08-14

    METHYLPHENIDATE HYDROCHLORIDE

    US Patent Number : 9295642

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 207960

    Patent Use Code : U-1827

    Delist Requested :

    Patent Use Description : A METHOD OF PROVIDING ...

    Patent Expiration Date : 2033-08-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    NEXTWAVE PHARMS

    METHYLPHENIDATE HYDROCHLORIDE

    arrow
    The Generic Rx Session
    Not Confirmed

    NEXTWAVE PHARMS

    U.S.A
    arrow
    The Generic Rx Session
    Not Confirmed

    Patent Expiration Date : 2033-08-14

    METHYLPHENIDATE HYDROCHLORIDE

    US Patent Number : 9295642

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 207960

    Patent Use Code : U-1827

    Delist Requested :

    Patent Use Description : A METHOD OF PROVIDING ...

    Patent Expiration Date : 2033-08-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF